Yoann Madec

Summary

Affiliation: Institut Pasteur
Country: France

Publications

  1. pmc Persistent Difficulties in Switching to Second-Line ART in Sub-Saharan Africa - A Systematic Review and Meta-Analysis
    Yoann Madec
    Institut Pasteur, Emerging Diseases Epidemiology Unit, Paris, France
    PLoS ONE 8:e82724. 2013
  2. pmc HIV prevalence and impact on renutrition in children hospitalised for severe malnutrition in Niger: an argument for more systematic screening
    Yoann Madec
    Unité d Epidémiologie des Maladies Emergentes, Institut Pasteur, Paris, France
    PLoS ONE 6:e22787. 2011
  3. doi request reprint Early control of HIV-1 infection in long-term nonprogressors followed since diagnosis in the ANRS SEROCO/HEMOCO cohort
    Yoann Madec
    INSERM U822, Le Kremlin Bicetre, France
    J Acquir Immune Defic Syndr 50:19-26. 2009
  4. doi request reprint Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: evidence from two developing countries
    Yoann Madec
    Unité d Epidémiologie des Maladies Emergentes, Institut Pasteur, 25 28 Rue du Docteur Roux, 75015 Paris, France
    AIDS 23:853-61. 2009
  5. ncbi request reprint Spontaneous control of viral load and CD4 cell count progression among HIV-1 seroconverters
    Yoann Madec
    Epidemiology Department, INSERM U569 INED Paris XI, Hopital de Bicetre, Le Kremlin Bicetre, France
    AIDS 19:2001-7. 2005
  6. doi request reprint Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial
    Didier Laureillard
    aFrench National Agency for Research on AIDS and Viral Hepatitis ANRS, Ho Chi Minh City, Vietnam bInstitut Pasteur du Cambodge, Phnom Penh, Cambodia cCambodian Health Committee, Phnom Penh, Cambodia dInstitut Pasteur, Paris, France eCalmette Hospital, Phnom Penh, Cambodia fKhmer Soviet Friendship Hospital, Phnom Penh, Cambodia gDonkeo Provincial Hospital, Takeo, Cambodia hMédecins Sans Frontières, Phnom Penh, Cambodia iSiem Reap Referral Hospital, Siem Reap, Cambodia jAssistance Publique Hôpitaux de Paris, Hopital Bicetre, Hôpitaux Universitaires Paris Sud, Le Kremlin Bicetre, France kProgram in Cellular and Molecular Medicine, Children s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    AIDS 27:2577-86. 2013
  7. doi request reprint Natural history of HIV-control since seroconversion
    Yoann Madec
    aInstitut Pasteur, Emerging Diseases Epidemiology Unit, Paris bINSERM U1018, Centre de Recherche en Epidémiologie et Santé des Populations, Le Kremlin Bicêtre cFaculté de Médecine Paris Sud, Universite Paris Sud, Paris dDepartment of Public Health, AP HP, Bicetre Hospital, Le Kremlin Bicetre, France eMedical Research Council, Clinical Trials Unit, London, UK fCluster Infectious Diseases, Department of Research, Center for Infection and Immunity Amsterdam CINIMA, Public Health Service, Amsterdam, The Netherlands gResearch Department of Infection and Population Health, UCL Medical School, London, UK hSan Paolo Hospital, Milan, Italy iInternational AIDS Vaccine Initiative, San Francisco, USA jRobert Koch Institut, Berlin, Germany kUlleval Hospital, Oslo, Norway lINSERM U1012, Le Kremlin Bicêtre mDepartment of Internal Medicine, AP HP, Bicetre Hospital, Le Kremlin Bicêtre nUniversité Paris Sud, Paris, France
    AIDS 27:2451-60. 2013
  8. ncbi request reprint Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia
    Yoann Madec
    Unité d Epidémiologie des Maladies Emergentes, Institut Pasteur, 25 28 Rue du Docteur Roux, 75015 Paris, France
    AIDS 21:351-9. 2007
  9. ncbi request reprint Undetectable viremia without antiretroviral therapy in patients with HIV seroconversion: an uncommon phenomenon?
    Yoann Madec
    Department of Epidemiology, INSERM U569 Paris 11, Le Kremlin Bicetre, France
    Clin Infect Dis 40:1350-4. 2005
  10. doi request reprint Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis
    Francois Xavier Blanc
    Pneumology Unit, Internal Medicine Department, Bicetre Hospital, Assistance Publique Hopitaux de Paris, Le Kremlin Bicetre, France
    N Engl J Med 365:1471-81. 2011

Detail Information

Publications19

  1. pmc Persistent Difficulties in Switching to Second-Line ART in Sub-Saharan Africa - A Systematic Review and Meta-Analysis
    Yoann Madec
    Institut Pasteur, Emerging Diseases Epidemiology Unit, Paris, France
    PLoS ONE 8:e82724. 2013
    ..We performed a systematic review and meta-analysis to estimate the incidence of switching to second-line ART in sub-Saharan Africa and its main programmatic determinants...
  2. pmc HIV prevalence and impact on renutrition in children hospitalised for severe malnutrition in Niger: an argument for more systematic screening
    Yoann Madec
    Unité d Epidémiologie des Maladies Emergentes, Institut Pasteur, Paris, France
    PLoS ONE 6:e22787. 2011
    ..Our goals were to evaluate the prevalence of HIV among children hospitalised for severe malnutrition (SM) at the Niamey national hospital (Niger), and to compare renutrition and mortality by HIV-status...
  3. doi request reprint Early control of HIV-1 infection in long-term nonprogressors followed since diagnosis in the ANRS SEROCO/HEMOCO cohort
    Yoann Madec
    INSERM U822, Le Kremlin Bicetre, France
    J Acquir Immune Defic Syndr 50:19-26. 2009
    ..To clarify early correlates and natural history of HIV long-term nonprogressors (LTNPs) since HIV diagnosis...
  4. doi request reprint Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: evidence from two developing countries
    Yoann Madec
    Unité d Epidémiologie des Maladies Emergentes, Institut Pasteur, 25 28 Rue du Docteur Roux, 75015 Paris, France
    AIDS 23:853-61. 2009
    ..In developing countries, access to laboratory tests remains limited, and the use of simple tools such as weight to monitor HIV-infected patients treated with antiretroviral therapy should be evaluated...
  5. ncbi request reprint Spontaneous control of viral load and CD4 cell count progression among HIV-1 seroconverters
    Yoann Madec
    Epidemiology Department, INSERM U569 INED Paris XI, Hopital de Bicetre, Le Kremlin Bicetre, France
    AIDS 19:2001-7. 2005
    ..To identify factors associated with sustained undetectable viraemia after HIV-1 seroconversion in treatment-naive patients, and to describe concomitant CD4 cell count progression...
  6. doi request reprint Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial
    Didier Laureillard
    aFrench National Agency for Research on AIDS and Viral Hepatitis ANRS, Ho Chi Minh City, Vietnam bInstitut Pasteur du Cambodge, Phnom Penh, Cambodia cCambodian Health Committee, Phnom Penh, Cambodia dInstitut Pasteur, Paris, France eCalmette Hospital, Phnom Penh, Cambodia fKhmer Soviet Friendship Hospital, Phnom Penh, Cambodia gDonkeo Provincial Hospital, Takeo, Cambodia hMédecins Sans Frontières, Phnom Penh, Cambodia iSiem Reap Referral Hospital, Siem Reap, Cambodia jAssistance Publique Hôpitaux de Paris, Hopital Bicetre, Hôpitaux Universitaires Paris Sud, Le Kremlin Bicetre, France kProgram in Cellular and Molecular Medicine, Children s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    AIDS 27:2577-86. 2013
    ....
  7. doi request reprint Natural history of HIV-control since seroconversion
    Yoann Madec
    aInstitut Pasteur, Emerging Diseases Epidemiology Unit, Paris bINSERM U1018, Centre de Recherche en Epidémiologie et Santé des Populations, Le Kremlin Bicêtre cFaculté de Médecine Paris Sud, Universite Paris Sud, Paris dDepartment of Public Health, AP HP, Bicetre Hospital, Le Kremlin Bicetre, France eMedical Research Council, Clinical Trials Unit, London, UK fCluster Infectious Diseases, Department of Research, Center for Infection and Immunity Amsterdam CINIMA, Public Health Service, Amsterdam, The Netherlands gResearch Department of Infection and Population Health, UCL Medical School, London, UK hSan Paolo Hospital, Milan, Italy iInternational AIDS Vaccine Initiative, San Francisco, USA jRobert Koch Institut, Berlin, Germany kUlleval Hospital, Oslo, Norway lINSERM U1012, Le Kremlin Bicêtre mDepartment of Internal Medicine, AP HP, Bicetre Hospital, Le Kremlin Bicêtre nUniversité Paris Sud, Paris, France
    AIDS 27:2451-60. 2013
    ..HIV-controllers spontaneously maintain HIV viremia at an undetectable level. We aimed to describe the delay to control from seroconversion, the duration of control, and risk factors for losing control...
  8. ncbi request reprint Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia
    Yoann Madec
    Unité d Epidémiologie des Maladies Emergentes, Institut Pasteur, 25 28 Rue du Docteur Roux, 75015 Paris, France
    AIDS 21:351-9. 2007
    ..HAART efficacy was evaluated in a real-life setting in Phnom Penh (Médecins Sans Frontières programme) among severely immuno-compromised patients...
  9. ncbi request reprint Undetectable viremia without antiretroviral therapy in patients with HIV seroconversion: an uncommon phenomenon?
    Yoann Madec
    Department of Epidemiology, INSERM U569 Paris 11, Le Kremlin Bicetre, France
    Clin Infect Dis 40:1350-4. 2005
    ....
  10. doi request reprint Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis
    Francois Xavier Blanc
    Pneumology Unit, Internal Medicine Department, Bicetre Hospital, Assistance Publique Hopitaux de Paris, Le Kremlin Bicetre, France
    N Engl J Med 365:1471-81. 2011
    ..Robust data are lacking with regard to the timing for the initiation of antiretroviral therapy (ART) in relation to the start of antituberculosis therapy...
  11. doi request reprint Switch to second-line ART in West African routine care: incidence and reasons for switching
    Jordi Landier
    Unité d Epidémiologie des Maladies Emergentes, Institut Pasteur, Paris, France
    AIDS Care 23:75-8. 2011
    ..The low rate of switch compares well with other studies, but was low compared to the expected rate of failure, and may indicate that physicians are reluctant to switch ART when treatment options are limited...
  12. doi request reprint Replication of Clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, in Aedes and Culex mosquitoes
    Sara Moutailler
    Génétique Moléculaire des Bunyavirus, Institut Pasteur, Paris, France
    Vector Borne Zoonotic Dis 10:681-8. 2010
    ..Moreover, infection with Clone 13 did not cause any important changes in mosquito's life-history traits compared to noninfected females. Nevertheless, it is likely that Clone 13 would not be efficiently transmitted by mosquito vectors...
  13. pmc Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in Cambodia
    Romain Micol
    Unité d Epidémiologie des Maladies Emergentes, Institut Pasteur, Paris, France
    PLoS ONE 5:e13856. 2010
    ..This study assessed the cost-effectiveness of three strategies for cryptococcosis prevention in HIV-infected patients...
  14. pmc Increased risk of Q151M and K65R mutations in patients failing stavudine-containing first-line antiretroviral therapy in Cambodia
    Janin Nouhin
    HIV Hepatitis Unit, Institut Pasteur in Cambodia, Phnom Penh, Cambodia Université Paris Diderot, Sorbonne Paris Cité, Paris, France
    PLoS ONE 8:e73744. 2013
    ....
  15. doi request reprint Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency
    Benedicte Neven
    Unité d Immuno Hématologie et Rhumatologie Pédiatrique, Hopital Necker Enfants Malades, Assistance Publique Hopitaux de Paris, Paris, France
    Blood 113:4114-24. 2009
    ..In most cases, HSCT enables long-term survival with infrequent sequelae. However, the occurrence of relatively late-onset complications is a concern that requires specific means of prevention and justifies careful patient follow-up...
  16. pmc Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study
    Clementine Schilte
    Unité Immunobiologie des Cellules Dendritiques, Department of Immunology, Institut Pasteur, Paris, France
    PLoS Negl Trop Dis 7:e2137. 2013
    ..Individuals were followed as part of a longitudinal study to investigate in details the long-term outcome of Chikungunya...
  17. ncbi request reprint Innate Immune Responses and Rapid Control of Inflammation in African Green Monkeys Treated or Not with Interferon-Alpha during Primary SIVagm Infection
    Beatrice Jacquelin
    Institut Pasteur, Regulation of Retroviral Infection Unit, Paris, France
    PLoS Pathog 10:e1004241. 2014
    ..This suggests that the sustained ISG expression and IA in HIV/SIVmac infections involves non-IFN-α products. ..
  18. pmc Dynamic shift from CD85j/ILT-2 to NKG2D NK receptor expression pattern on human decidual NK during the first trimester of pregnancy
    Romain Marlin
    Regulation of Retroviral Infection Unit, Department of Virology, Institut Pasteur, Paris, France
    PLoS ONE 7:e30017. 2012
    ..Thus, the phenotypic evolutions of decidual NK cells described in this present study may preserve their activation/inhibition balance during the first trimester of pregnancy...
  19. pmc Differential responses of the mosquito Aedes albopictus from the Indian Ocean region to two chikungunya isolates
    Estelle Martin
    Génétique Moléculaire des Bunyavirus, Institut Pasteur, 25 28 Rue du Dr Roux, Paris Cedex 15, France
    BMC Ecol 10:8. 2010
    ..An important question is whether this variant is associated with adverse effects impacting some mosquito life-history traits such as survival and reproduction...